Skip to main content

Table 4 Associations between breast cancer risk factors and tumor molecular subtypes in Kenyan breast cancer patients (N=821*)

From: Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya

   

Tumor subtypes

 
 

Luminal A n=286

Luminal B n=294

Luminal B vs. Luminal A

HER2-enriched n=88

HER2-enriched vs. Luminal A

Triple negative n=153

Triple negative vs. Luminal A

 

N

%

N

%

OR (95% CI)†

P†

N

%

OR (95% CI)†

P†

N

%

OR (95% CI)†

P†

Age at diagnosis/year

 < 50

142

50.2

180

61.4

1.00 (Ref)

 

44

50.0

1.00 (Ref)

 

77

50.3

1.00 (Ref)

 

 ≥ 50

141

49.8

113

38.6

0.87 (0.36, 2.06)

0.74

44

50.0

1.84 (0.57, 5.92)

0.30

76

49.7

0.52 (0.20, 1.40)

0.20

BMI/ kg/m2

 Normal (< 25.0)

60

27.3

71

30.5

1.00 (Ref)

 

29

41.4

1.00 (Ref)

 

43

32.6

1.00 (Ref)

 

 Overweight (25.0–29.9)

84

38.2

99

42.5

1.09 (0.66, 1.82)

0.73

25

35.7

0.55 (0.28, 1.11)

0.10

49

37.1

0.91 (0.49, 1.68)

0.75

 Obese (≥ 30.0)

76

34.5

63

27.0

0.76 (0.43, 1.33)

0.33

16

22.9

0.36 (0.16, 0.81)

0.013

40

30.3

0.89 (0.46, 1.72)

0.73

 Trend‡

    

0.87 (0.66, 1.15)

0.32

  

0.59 (0.39, 0.88)

0.011

  

0.94 (0.68, 1.32)

0.73

Premenopausal: BMIa

 Normal (< 25.0)

36

32.4

51

34.7

1.00 (Ref)

 

16

45.7

1.00 (Ref)

 

23

38.3

1.00 (Ref)

 

 Overweight (25.0–29.9)

43

38.7

59

40.1

0.98 (0.51, 1.88)

0.95

11

31.4

0.52 (0.19, 1.40)

0.20

16

26.7

0.49 (0.20, 1.21)

0.12

 Obese (≥ 30.0)

32

28.8

37

25.2

0.78 (0.37, 1.61)

0.49

8

22.9

0.44 (0.14, 1.35)

0.15

21

35.0

0.84 (0.34, 2.07)

0.71

 Trend‡

    

0.89 (0.62, 1.27)

0.52

  

0.65 (0.37, 1.1)

0.13

  

0.91 (0.57, 1.45)

0.69

Postmenopausal: BMIa

 Normal (< 25.0)

24

22.0

20

23.5

1.00 (Ref)

 

13

37.1

1.00 (Ref)

 

20

27.8

1.00 (Ref)

 

 Overweight (25.0–29.9)

41

37.6

40

47.1

1.35 (0.57, 3.20)

0.50

14

40.0

0.48 (0.17, 1.40)

0.18

33

45.8

1.70 (0.68, 4.26)

0.25

 Obese (≥ 30.0)

44

40.4

25

29.4

1.10 (0.43, 2.82)

0.84

8

22.9

0.24 (0.07, 0.81)

0.022

19

26.4

1.28 (0.48, 3.46)

0.62

 Trend‡

    

1.02 (0.64, 1.64)

0.92

  

0.47 (0.26, 0.88)

0.018

  

1.10 (0.68, 1.78)

0.71

Age at menarche/year

 ≤ 13 (9–13)

69

25.8

71

24.8

1.00 (Ref)

 

23

26.4

1.00 (Ref)

 

33

22.9

1.00 (Ref)

 

 14

68

25.4

69

24.1

1.28 (0.73, 2.25)

0.39

26

29.9

1.65 (0.73, 3.74)

0.23

37

25.7

1.43 (0.73, 2.81)

0.30

 ≥ 15 (15–20)

131

48.9

146

51.1

1.29 (0.79, 2.13)

0.31

38

43.7

1.32 (0.64, 2.73)

0.46

74

51.4

1.43 (0.78, 2.60)

0.24

 Trend‡

    

1.13 (0.88, 1.45)

0.34

  

1.12 (0.78, 1.59)

0.54

  

1.18 (0.88, 1.58)

0.28

Age at first pregnancy/year

 < 20

72

26.2

58

19.9

1.00 (Ref)

 

31

35.6

1.00 (Ref)

 

51

34.0

1.00 (Ref)

 

 20–24

121

44.0

133

45.5

1.51 (0.84, 2.70)

0.17

30

34.5

0.64 (0.29, 1.37)

0.25

69

46.0

0.81 (0.43, 1.51)

0.51

 25–29

51

18.5

62

21.2

1.76 (0.85, 3.65)

0.13

16

18.4

0.92 (0.34, 2.51)

0.87

19

12.7

0.67 (0.28, 1.60)

0.37

 Nulliparousb or ≥ 30

31

11.3

39

13.4

1.06 (0.40, 2.82)

0.90

10

11.5

1.18 (0.31, 4.53)

0.81

11

7.3

0.66 (0.20, 2.18)

0.50

 Trend‡

    

1.09 (0.82, 1.45)

0.54

  

1.02 (0.67, 1.56)

0.93

  

0.84 (0.59, 1.20)

0.33

Parity

 Nulliparousb

14

4.9

20

6.8

1.09 (0.30, 3.88)

0.90

4

4.5

0.56 (0.07, 4.77)

0.60

3

2.0

0.67 (0.11, 4.12)

0.66

 Parous

272

95.1

274

93.2

1.00 (Ref)

 

84

95.5

1.00 (Ref)

 

150

98.0

1.00 (Ref)

 

Number of children

 1–2

73

26.8

101

36.9

1.00 (Ref)

 

19

22.6

1.00 (Ref)

 

31

20.7

1.00 (Ref)

 

 3–4

113

41.5

101

36.9

0.47 (0.28, 0.79)

0.005

26

31.0

0.85 (0.37, 1.98)

0.71

59

39.3

1.16 (0.59, 2.29)

0.66

 ≥ 5

86

31.6

72

26.3

0.45 (0.23, 0.87)

0.018

39

46.4

1.71 (0.65, 4.53)

0.28

60

40.0

1.27 (0.56, 2.89)

0.56

 Trend‡

    

0.65 (0.47, 0.90)

0.0099

  

1.34 (0.82, 2.20)

0.24

  

1.11 (0.75, 1.66)

0.60

Cumulative breastfeeding duration/monthc

 Q1: 1–< 39

64

24.3

88

33.2

1.00 (Ref)

 

15

18.3

1.00 (Ref)

 

20

13.9

1.00 (Ref)

 

 Q2: 39–< 62

59

22.4

68

25.7

0.99 (0.54, 1.80)

0.97

22

26.8

2.48 (0.97, 6.33)

0.058

40

27.8

2.98 (1.33, 6.71)

0.008

 Q3: 62–< 96

71

27.0

53

20.0

0.66 (0.33, 1.30)

0.23

14

17.1

0.80 (0.27, 2.39)

0.69

40

27.8

1.80 (0.74, 4.38)

0.20

 Q4: ≥ 96

69

26.2

56

21.1

0.99 (0.44, 2.20)

0.97

31

37.8

1.30 (0.40, 4.16)

0.66

44

30.6

1.87 (0.69, 5.07)

0.22

 Trend‡

    

0.93 (0.71, 1.20)

0.56

  

0.97 (0.67, 1.41)

0.88

  

1.12 (0.82, 1.52)

0.47

Mean breastfeeding duration per child/month

 < 12

34

12.9

48

18.1

1.00 (Ref)

 

11

13.4

1.00 (Ref)

 

23

16.0

1.00 (Ref)

 

 12– 23

142

54.0

139

52.5

0.65 (0.35, 1.21)

0.18

49

59.8

1.24 (0.47, 3.29)

0.66

71

49.3

0.75 (0.36, 1.59)

0.46

 ≥ 24

87

33.1

78

29.4

0.64 (0.32, 1.27)

0.20

22

26.8

1.21 (0.42, 3.52)

0.73

50

34.7

1.09 (0.49, 2.43)

0.83

 Trend‡

    

0.84 (0.60, 1.16)

0.28

  

1.07 (0.66, 1.72)

0.80

  

1.13 (0.76, 1.66)

0.55

Age at first pregnancy and Number of children

 Age 25+ years, 1–3 births

54

20.7

64

23.5

1.00 (Ref)

 

15

17.9

1.00 (Ref)

 

20

13.6

1.00 (Ref)

 

 Age < 25 years, 1–3 births

80

30.7

93

34.2

0.93 (0.52, 1.67)

0.81

19

22.6

0.82 (0.31, 2.15)

0.69

47

32.0

1.39 (0.65, 2.97)

0.40

 Age 25+ years, 4+ births

15

5.7

18

6.6

0.77 (0.29, 2.05)

0.60

8

9.5

2.10 (0.58, 7.54)

0.26

7

4.8

1.12 (0.29, 4.27)

0.87

 Age < 25 years, 4+ births

112

42.9

97

35.7

0.55 (0.29, 1.05)

0.068

42

50.0

1.31 (0.51, 3.39)

0.58

73

49.7

1.38 (0.62, 3.08)

0.43

 Trend‡

    

0.81 (0.66, 0.99)

0.041

  

1.16 (0.86, 1.56)

0.33

  

1.07 (0.84, 1.37)

0.58

Number of children and Cumulative breastfeeding duration

 Nulliparous or ≤ 3 children and < 62 months

117

42.2

146

51.2

1.00 (Ref)

 

31

36.0

1.00 (Ref)

 

51

34.7

1.00 (Ref)

 

 ≤ 3 children and ≥ 62 months

30

10.8

25

8.8

0.61 (0.30, 1.22)

0.16

6

7.0

0.41 (0.11, 1.56)

0.19

17

11.6

1.19 (0.53, 2.66)

0.68

 ≥ 4 children and < 62 months

20

7.2

30

10.5

0.89 (0.38, 2.07)

0.79

10

11.6

2.34 (0.78, 6.99)

0.13

12

8.2

1.31 (0.49, 3.53)

0.59

 ≥ 4 children and ≥ 62 months

110

39.7

84

29.5

0.52 (0.30, 0.89)

0.02

39

45.3

1.26 (0.57, 2.78)

0.56

67

45.6

0.96 (0.50, 1.84)

0.91

 Trend‡

    

0.81 (0.68, 0.97)

0.02

  

1.11 (0.85, 1.44)

0.44

  

0.99 (0.80, 1.22)

0.91

Menopausal statusa

 Premenopausal

144

50.3

174

59.4

1.00 (Ref)

 

44

50.0

1.00 (Ref)

 

68

44.7

1.00 (Ref)

 

 Postmenopausal

142

49.7

119

40.6

0.69 (0.32, 1.48)

0.33

44

50.0

0.69 (0.22, 2.10)

0.51

84

55.3

1.82 (0.78, 4.28)

0.17

Age at menopause/year

 Premenopausal

144

50.3

174

59.4

N/A

44

50.0

N/A

68

44.7

N/A

 < 50 years

58

22.5

58

20.9

1.00 (Ref)

 

28

33.7

1.00 (Ref)

 

44

32.1

1.00 (Ref)

 

 > 50 years

56

21.7

46

16.6

0.88 (0.45, 1.74)

0.72

11

13.3

0.38 (0.15, 0.997)

0.049

25

18.3

0.66 (0.31, 1.40)

0.28

  1. *Seventeen cases were excluded from analyses because of their missing data for HER2 status. † Point estimates and 95% confidence intervals were from multivariable models, adjusting for the same series of covariates (except where noticed): age at diagnosis, BMI, age at menarche, age at first pregnancy, number of children, mean breastfeeding duration per child, age at menopause, family history of breast cancer in first-degree female relative, occupation, education level, and location of the facility. Estimates of numbers of children, cumulative and mean breastfeeding duration, and combined age at first pregnancy, and number of children were computed among parous women. ‡ Results were from the trend analysis using the categorical risk factor as a trend. a Multivariable modeling analysis without adjusting for age at menopause. bWomen who reported never pregnant, never gave birth, and had no child were grouped as "Nulliparous" in modeling analyses. c Multivariable modeling analysis without adjusting for mean breastfeeding duration per child. BMI, body mass index; CI, confidence interval; HER2, human epidermal growth factor receptor-2; OR, odds ratio; Q, quartile